Adjuvant Multiagent Chemotherapy Regimens Associated with OS Benefit Following Resection of Localised Pancreatic Adenocarcinoma Following Preoperative (m)FOLFIRINOX By Ogkologos - March 11, 2025 667 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a retrospective cohort study Source RELATED ARTICLESMORE FROM AUTHOR No OS Improvement with CDK4/6 Inhibitors Used in First- Compared with Second-Line Treatment in Patients with HR-positive, HER2-negative ABC Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe MOST POPULAR Does Living Near Power Lines Increase My Risk of Cancer? March 17, 2022 Does Too Much Fructose Help Colorectal Cancers Grow? October 29, 2021 ¿Tener paneles solares o vivir cerca de una granja solar puede... April 6, 2023 Survivor’s Lucky Chance Encounter with Her Old Surgeon Leads to an... August 6, 2021 Load more HOT NEWS Measurable Residual Disease Adapted Consolidation Strategy After Quadruplet Induction Therapy for... Picking out the sound of tumours FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma How MRI add-ons could accelerate the development of new treatments
